Biobin 100 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Biobin 100 mg Injection

Biobin 100 mg Injection

Biobin 100 mg Injection contains cytarabine, an antimetabolite medicine used in the treatment of certain blood cancers. It is supplied as a 100 mg/1 mL injection for administration by a healthcare professional. Cytarabine works by interfering with DNA synthesis and stopping the growth and multiplication of cancer cells.

BUY NOW

Category

Biobin 100 mg Injection is used in chemotherapy regimens for blood cancers such as acute myeloid leukemia and acute lymphocytic leukemia, and may also be used for certain cancers involving the tissues around the brain and spinal cord. Cytarabine acts as a pyrimidine nucleoside analogue and inhibits DNA synthesis in rapidly dividing cancer cells. It may be administered intravenously or subcutaneously depending on the prescribed treatment protocol. Treatment requires medical supervision with monitoring of blood counts, liver function, and other potential toxicities.

Technical Specification

Specification Details
Active Ingredient Cytarabine
Strength 100 mg
Concentration 100 mg/mL
Dosage Form Injection
Route of Administration Intravenous or Subcutaneous
Pack Size 1 mL vial

Product Also Known As

Biobin 100 mg Injection, Cytarabine 100 mg Injection, Biobin Cytarabine Injection, Cytarabine Cancer Injection, Cytarabine Chemotherapy Injection, Antimetabolite Cancer Injection